No offense to Baykar, but they remain a single product company more or less for the time being. Akinci sales are nowhere near the numbers or TB2, Kizilelma is not on sale yet.
TB2 will be the cash cow for now but eventually a market is saturated, so they need to diversify and deliver some good...